The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
Kashappa Goud Desai
Advertisement
Kashappa Goud Desai, PhD, is investigator, Biopharmaceutical Product Sciences, GlaxoSmithKline, kashappa-goud.x.desai@gsk.com
Articles by Kashappa Goud Desai
Advertisement
Latest Updated Articles
Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ BatchesPublished: June 2nd 2017 | Updated:
Advertisement
Advertisement
